Loading...
OTCM
NUMD
Market cap2mUSD
Dec 05, Last price  
0.02USD
1Q
-22.49%
Jan 2017
-90.24%
IPO
-97.56%
Name

Nu-Med Plus Inc

Chart & Performance

D1W1MN
OTCM:NUMD chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
12.90%
Rev. gr., 5y
%
Revenues
0k
Net income
-68k
L-45.55%
-262,744-332,290-1,192,732-1,109,8979,652,4883,577,002-1,188,846-1,054,231-2,023,321-830,061-131,167-125,526-68,345
CFO
-4k
L-93.32%
-830-104,185-140,483-158,257-329,383-180,264-430,510-467,568-567,341-414,799-206,831-38,480-66,389-4,433

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Nu-Med Plus, Inc., a medical device company, engages in the design, development, enhancement, and commercialization of medical devices worldwide. It develops a hospital nitric oxide delivery system, a clinical nitric oxide delivery system, a mobile rechargeable device to deliver nitric oxide gas, and a nitric oxide system that can be used for research applications. The company serves hospitals, health systems, and the medical community. Nu-Med Plus, Inc. was incorporated in 2011 and is headquartered in Salt Lake City, Utah.
IPO date
Aug 02, 2013
Employees
2
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT